EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for URGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.2848
March 31, 2026 -0.4698
December 31, 2025 -0.5453
September 30, 2025 -0.6939
June 30, 2025 -1.046
March 31, 2025 -0.9245
December 31, 2024 -0.7976
September 30, 2024 -0.5492
June 30, 2024 -0.9072
March 31, 2024 -0.9672
December 31, 2023 -0.7196
September 30, 2023 -0.6774
June 30, 2023 -1.029
March 31, 2023 -1.298
December 31, 2022 -1.224
September 30, 2022 -1.133
June 30, 2022 -1.176
March 31, 2022 -1.254
December 31, 2021 -1.268
Date Value
September 30, 2021 -1.350
June 30, 2021 -1.174
March 31, 2021 -1.166
December 31, 2020 -1.377
September 30, 2020 -1.306
June 30, 2020 -1.441
March 31, 2020 -1.786
December 31, 2019 -1.857
September 30, 2019 -1.064
June 30, 2019 -1.079
March 31, 2019 -1.109
December 31, 2018 -1.463
September 30, 2018 -1.276
June 30, 2018 -1.142
March 31, 2018 -0.8765
December 31, 2017 -0.74
September 30, 2017 -0.02
June 30, 2017 -0.70

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Insmed, Inc. -0.0609
Xencor, Inc. -0.2864
MeiraGTx Holdings Plc 1.713
IDEAYA Biosciences, Inc. -1.222
ACADIA Pharmaceuticals, Inc. 0.1822